-
Loading metrics
Open Access
Peer-reviewed
Research Article
Cysteine-Rich Secretory Protein-3 (CRISP3) Is Strongly Up-Regulated in Prostate Carcinomas with the TMPRSS2-ERG Fusion Gene
-
Franclim R. Ribeiro ,
Contributed equally to this work with: Franclim R. Ribeiro, Paula Paulo
Affiliations Department of Genetics, Portuguese Oncology Institute-Porto, Porto, Portugal, Cancer Genetics Group, Research Centre of the Portuguese Oncology Institute-Porto, Porto, Portugal, Department of Cancer Prevention, Institute for Cancer Research, Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway, Centre for Cancer Biomedicine, Faculty of Medicine, University of Oslo, Oslo, Norway
⨯ -
Paula Paulo ,
Contributed equally to this work with: Franclim R. Ribeiro, Paula Paulo
Affiliations Department of Genetics, Portuguese Oncology Institute-Porto, Porto, Portugal, Cancer Genetics Group, Research Centre of the Portuguese Oncology Institute-Porto, Porto, Portugal, Department of Cancer Prevention, Institute for Cancer Research, Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway, Centre for Cancer Biomedicine, Faculty of Medicine, University of Oslo, Oslo, Norway
⨯ -
Vera L. Costa,
Affiliations Department of Genetics, Portuguese Oncology Institute-Porto, Porto, Portugal, Cancer Epigenetics Group, Research Centre of the Portuguese Oncology Institute, Porto, Portugal, Department of Cancer Prevention, Institute for Cancer Research, Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway, Centre for Cancer Biomedicine, Faculty of Medicine, University of Oslo, Oslo, Norway
⨯ -
João D. Barros-Silva,
Affiliations Department of Genetics, Portuguese Oncology Institute-Porto, Porto, Portugal, Cancer Genetics Group, Research Centre of the Portuguese Oncology Institute-Porto, Porto, Portugal
⨯ -
João Ramalho-Carvalho,
Affiliations Department of Genetics, Portuguese Oncology Institute-Porto, Porto, Portugal, Cancer Epigenetics Group, Research Centre of the Portuguese Oncology Institute, Porto, Portugal
⨯ -
Carmen Jerónimo,
Affiliations Department of Genetics, Portuguese Oncology Institute-Porto, Porto, Portugal, Cancer Epigenetics Group, Research Centre of the Portuguese Oncology Institute, Porto, Portugal, Department of Pathology and Molecular Immunology, Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, Porto, Portugal
⨯ -
Rui Henrique,
Affiliations Department of Pathology, Portuguese Oncology Institute-Porto, Porto, Portugal, Cancer Epigenetics Group, Research Centre of the Portuguese Oncology Institute, Porto, Portugal, Department of Pathology and Molecular Immunology, Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, Porto, Portugal
⨯ -
Guro E. Lind,
Affiliations Department of Cancer Prevention, Institute for Cancer Research, Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway, Centre for Cancer Biomedicine, Faculty of Medicine, University of Oslo, Oslo, Norway
⨯ -
Rolf I. Skotheim,
Affiliations Department of Cancer Prevention, Institute for Cancer Research, Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway, Centre for Cancer Biomedicine, Faculty of Medicine, University of Oslo, Oslo, Norway
⨯ -
Ragnhild A. Lothe ,
¶These authors also contributed equally to this work.
Affiliations Department of Cancer Prevention, Institute for Cancer Research, Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway, Centre for Cancer Biomedicine, Faculty of Medicine, University of Oslo, Oslo, Norway
⨯ -
Manuel R. Teixeira
* E-mail: manuel.teixeira@ipoporto.min-saude.pt
¶These authors also contributed equally to this work.
Affiliations Department of Genetics, Portuguese Oncology Institute-Porto, Porto, Portugal, Cancer Genetics Group, Research Centre of the Portuguese Oncology Institute-Porto, Porto, Portugal, Department of Pathology and Molecular Immunology, Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, Porto, Portugal, Centre for Cancer Biomedicine, Faculty of Medicine, University of Oslo, Oslo, Norway
⨯
Cysteine-Rich Secretory Protein-3 (CRISP3) Is Strongly Up-Regulated in Prostate Carcinomas with the TMPRSS2-ERG Fusion Gene
- Franclim R. Ribeiro,
- Paula Paulo,
- Vera L. Costa,
- João D. Barros-Silva,
- João Ramalho-Carvalho,
- Carmen Jerónimo,
- Rui Henrique,
- Guro E. Lind,
- Rolf I. Skotheim,
- Ragnhild A. Lothe
- Published: July 21, 2011
- https://doi.org/10.1371/journal.pone.0022317